Despite improved antimicrobial therapy and preventative practices, hospital acquired and ventilator associated pneumonia remain important causes of morbidity and mortality

HAP & VAP continues to challenge intensivists, microbiologists, ID physicians and laboratory staff alike, from initial diagnosis to choice of effective treatment regimens.

Presentation Details Downloads
Diagnosis, definitions & treatment

Welcome and Overview

Bob Masterton, Ayrshire

Download Video

Diagnosis & defi nitions of HAP/VAP – where are we now?

Gary French, London

Download Video
Download Slides

Treatment of HAP/VAP – strategies & challenges

Ethan Rubinstein, Canada

Download Video
Download Slides
Reducing patient harm

HAP/VAP care bundle interventions – a UK approach

Bob Masterton, Ayrshire

Download Video
Download Slides

Reducing patient harm in critical care: the matching Michigan experience

Bradford Winters, Baltimore, USA

Download Video
Download Slides
Advances in HAP/VAP management

The impact of non-antimicrobial interventions

Duncan Wyncoll, London

Download Video
Download Slides

The impact of recent antimicrobial interventions – the PK/PD debate & what the evidence says

William Hope, Manchester

Download Video
Download Slides

Novel biomarkers for infection & sepsis

Paul Dark, Manchester

Download Video

Event details

2 September 2010

Royal College of Physicians, Edinburgh

GP? Pharmacist? Researcher? Social Scientist? Whatever field you work in, if you’re committed to fighting infection then we want you to join us as a BSAC Member.
Become a member
I have read and agree to the Privacy Policy

Having trouble finding what you're after?

Top